The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of BRAF V600E and KRAS exon 2 mutations in microsatellite stable (MSS), stage III colon cancers (CC) from patients (pts) treated with adjuvant FOLFOX+/- cetuximab: A pooled analysis of 3934 pts from the PETACC8 and N0147 trials.
 
Julien Taieb
Honoraria - Bayer; Merck Serono; Roche Pharma AG; Sanofi
Consulting or Advisory Role - Celgene; Merck Serono; Roche Pharma AG
Research Funding - Genentech (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Celgene; Merck Serono; Roche Pharma AG
 
Karine Le Malicot
No Relationships to Disclose
 
Frederique Madeleine Penault-Llorca
No Relationships to Disclose
 
Olivier Bouche
Honoraria - Lilly; Novartis
Consulting or Advisory Role - Merck Serono; Roche Pharma AG
 
Qian Shi
No Relationships to Disclose
 
Stephen N. Thibodeau
No Relationships to Disclose
 
Josep Tabernero
Consulting or Advisory Role - Amgen; Celgene; Chugai Pharma; ImClone Systems; Lilly; Merck KGaA; Millennium; Novartis; Roche/Genentech; Sanofi; Symphony Evolution; Taiho Pharmaceutical
 
Enrico Mini
No Relationships to Disclose
 
Richard M. Goldberg
Honoraria - Biothera; Lilly; Sanofi
Research Funding - Bayer (Inst); Immunomedics (Inst); Merck (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Merck KGaA; Sanofi
 
Gunnar Folprecht
Honoraria - Bayer; Lilly/ImClone; Merck KGaA
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly/ImClone; Merck KGaA; Roche/Genentech
Research Funding - Merck KGaA
 
Jean-Luc Van Laethem
No Relationships to Disclose
 
Daniel J. Sargent
No Relationships to Disclose
 
Steven R. Alberts
No Relationships to Disclose
 
Pierre Laurent-Puig
Honoraria - Sanofi
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Genomic Health; IntegraGen; Merck Serono
Travel, Accommodations, Expenses - IntegraGen; MSD Oncology
 
Frank A. Sinicrope
Stock and Other Ownership Interests - Celgene; Gilead Sciences; Pharmacyclics
Travel, Accommodations, Expenses - Roche Pharma AG; Ventana Medical Systems